IL173895A0 - Imidazopyridine derivatives and pharmaceutical compositions containing the same - Google Patents

Imidazopyridine derivatives and pharmaceutical compositions containing the same

Info

Publication number
IL173895A0
IL173895A0 IL173895A IL17389506A IL173895A0 IL 173895 A0 IL173895 A0 IL 173895A0 IL 173895 A IL173895 A IL 173895A IL 17389506 A IL17389506 A IL 17389506A IL 173895 A0 IL173895 A0 IL 173895A0
Authority
IL
Israel
Prior art keywords
same
pharmaceutical compositions
compositions containing
imidazopyridine derivatives
imidazopyridine
Prior art date
Application number
IL173895A
Other languages
English (en)
Original Assignee
Nycomed Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Gmbh filed Critical Nycomed Gmbh
Publication of IL173895A0 publication Critical patent/IL173895A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Psychology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
IL173895A 2003-10-01 2006-02-23 Imidazopyridine derivatives and pharmaceutical compositions containing the same IL173895A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03022053 2003-10-01
PCT/EP2004/052378 WO2005030771A1 (en) 2003-10-01 2004-09-30 Imidazopyridine-derivatives as inductible no-synthase inhibitors

Publications (1)

Publication Number Publication Date
IL173895A0 true IL173895A0 (en) 2006-07-05

Family

ID=34384571

Family Applications (1)

Application Number Title Priority Date Filing Date
IL173895A IL173895A0 (en) 2003-10-01 2006-02-23 Imidazopyridine derivatives and pharmaceutical compositions containing the same

Country Status (19)

Country Link
US (2) US7468377B2 (cg-RX-API-DMAC7.html)
EP (1) EP1675854B1 (cg-RX-API-DMAC7.html)
JP (1) JP2007507467A (cg-RX-API-DMAC7.html)
KR (1) KR20060092220A (cg-RX-API-DMAC7.html)
CN (1) CN100415745C (cg-RX-API-DMAC7.html)
AT (1) ATE399169T1 (cg-RX-API-DMAC7.html)
AU (1) AU2004276015A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0414972A (cg-RX-API-DMAC7.html)
CA (1) CA2540083A1 (cg-RX-API-DMAC7.html)
DE (1) DE602004014630D1 (cg-RX-API-DMAC7.html)
EA (1) EA010261B1 (cg-RX-API-DMAC7.html)
ES (1) ES2309567T3 (cg-RX-API-DMAC7.html)
IL (1) IL173895A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA06003349A (cg-RX-API-DMAC7.html)
NO (1) NO20061344L (cg-RX-API-DMAC7.html)
NZ (1) NZ546437A (cg-RX-API-DMAC7.html)
RS (1) RS20060196A (cg-RX-API-DMAC7.html)
WO (1) WO2005030771A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200601642B (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06003351A (es) * 2003-10-01 2006-06-08 Altana Pharma Ag Derivados de imidazopiridina como inhibidores de no-sintasa inducible.
KR20060092220A (ko) * 2003-10-01 2006-08-22 알타나 파마 아게 유도성 no-신타아제 저해제로서의 이미다조피리딘 유도체
KR20060092221A (ko) 2003-10-01 2006-08-22 알타나 파마 아게 유도성 no-신타제 억제제로서의이미다조(4,5-b)피리딘 유도체
EP1670798A1 (en) 2003-10-01 2006-06-21 Altana Pharma AG Aminopyridine-derivatives as inductible no-synthase inhibitors
AR057525A1 (es) * 2005-10-03 2007-12-05 Astrazeneca Ab Compuestos inhibidores selectivos de gsk3 y un proceso para su preparacion
AR055669A1 (es) * 2005-10-03 2007-08-29 Astrazeneca Ab Derivados de 3h - imidazo[4, 5 -b]piridina como inhibidores selectivos de gsk3, metodos e internediarios para su preparacion, composiciones farmaceuticas que los contienen y su uso para la elaboracion de un medicamento para el tratamiento de enfermedades neurodegenerativas y mentales.
ES2573412T3 (es) * 2010-09-10 2016-06-07 Shionogi & Co., Ltd. Derivado de imidazol de heteroanillo fusionado que tiene efecto de AMPK (activacion de proteina cinasa activada por monofosfato de adenosina)
GB201512635D0 (en) 2015-07-17 2015-08-26 Ucl Business Plc Uses of therapeutic compounds

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4045564A (en) * 1974-02-18 1977-08-30 Ab Hassle Benzimidazole derivatives useful as gastric acid secretion inhibitors
SE418966B (sv) 1974-02-18 1981-07-06 Haessle Ab Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan
GB8307865D0 (en) 1983-03-22 1983-04-27 Fujisawa Pharmaceutical Co Benzimidazole derivatives
SE512835C2 (sv) 1996-01-08 2000-05-22 Astrazeneca Ab Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare
AUPP873799A0 (en) 1999-02-17 1999-03-11 Fujisawa Pharmaceutical Co., Ltd. Pyridine compounds
ATE384722T1 (de) * 2002-03-27 2008-02-15 Nycomed Gmbh Alkoxypyridinderivate
AU2003280578A1 (en) * 2002-10-30 2004-05-25 Ajinomoto Co., Inc. Heterocyclic compounds
MXPA06003351A (es) * 2003-10-01 2006-06-08 Altana Pharma Ag Derivados de imidazopiridina como inhibidores de no-sintasa inducible.
KR20060092220A (ko) * 2003-10-01 2006-08-22 알타나 파마 아게 유도성 no-신타아제 저해제로서의 이미다조피리딘 유도체
KR20060092221A (ko) 2003-10-01 2006-08-22 알타나 파마 아게 유도성 no-신타제 억제제로서의이미다조(4,5-b)피리딘 유도체
BRPI0414873A (pt) 2003-10-01 2006-12-12 Altana Pharma Ag derivados de imidazopiridina como inibidores de no-sintase induzìveis
EP1670798A1 (en) 2003-10-01 2006-06-21 Altana Pharma AG Aminopyridine-derivatives as inductible no-synthase inhibitors

Also Published As

Publication number Publication date
ZA200601642B (en) 2007-05-30
US7468377B2 (en) 2008-12-23
CN1856491A (zh) 2006-11-01
NZ546437A (en) 2009-09-25
RS20060196A (sr) 2008-08-07
NO20061344L (no) 2006-03-24
EA010261B1 (ru) 2008-06-30
AU2004276015A1 (en) 2005-04-07
US20090036482A1 (en) 2009-02-05
EA200600608A1 (ru) 2006-10-27
US20070043073A1 (en) 2007-02-22
ES2309567T3 (es) 2008-12-16
JP2007507467A (ja) 2007-03-29
EP1675854B1 (en) 2008-06-25
BRPI0414972A (pt) 2006-11-07
CN100415745C (zh) 2008-09-03
MXPA06003349A (es) 2006-06-08
KR20060092220A (ko) 2006-08-22
HK1096548A1 (zh) 2007-06-01
CA2540083A1 (en) 2005-04-07
ATE399169T1 (de) 2008-07-15
DE602004014630D1 (de) 2008-08-07
WO2005030771A1 (en) 2005-04-07
EP1675854A1 (en) 2006-07-05

Similar Documents

Publication Publication Date Title
IL185275A0 (en) N-sulphonylpyrrole derivatives and pharmaceutical compositions containing the same
GEP20074148B (en) Pyrrolo-triazine aniline compounds useful as kinase inhibitors
SE9904652D0 (sv) Novel Compounds
DE602004021472D1 (en) Pyrimiidinverbindungen
IL181271A0 (en) Triazolophthalazine derivatives and pharmaceutical compositions containing the same
TR200302268T4 (tr) NOS inhibitörleri olarak yararlı N-heterosiklik türevler.
AU2003228770A8 (en) Substituted pyrazolopyrimidines
IL166271A0 (en) Pyrrolidinedione substituted piperidine phthalazone derivatives and pharmaceutical compositions containing the same
SG154433A1 (en) Phthalazine derivatives as parp inhibitors
IL164511A0 (en) Heterocyclic compounds
IL173810A0 (en) Imidazopyridine derivatives and pharmaceutical compositions containing the same
SE0302139D0 (sv) Novel compounds
GB0308201D0 (en) Novel compounds
TW200604197A (en) New compounds
IL163625A0 (en) Alkoxy-pyridine derivatives and pharmaceutical compositions containing the same
IL159554A0 (en) Tricyclic imidazopyridine derivatives and pharmaceutical compositions containing the same
SE0101038D0 (sv) Novel compounds
SE0303280D0 (sv) Novel compounds
ATE419242T1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
IL151198A0 (en) Tricyclic imidazopyridine derivatives and pharmaceutical compositions containing the same
MXPA06003345A (es) Derivados de aminopiridina como inhibidores de la no-sintasa inducible.
IL173895A0 (en) Imidazopyridine derivatives and pharmaceutical compositions containing the same
IL173809A0 (en) Imidazopyridine derivatives and pharmaceutical compositions containing the same
AU2002248531A1 (en) Pyrazolopyriadine derivatives
SE0302755D0 (sv) Novel compounds